Cancer of Unknown Primary (CUP) Claims in Ireland: When the Work-Up Falls Short
Last reviewed: . Firm: Gary Matthews Solicitors, 3rd Floor, Ormond Building, 31-36 Ormond Quay Upper, Dublin D07. Phone 01 9036408.
In short: A personal injury claim for cancer of unknown primary (CUP) does not turn on the missing primary. CUP is a confirmed cancer found as metastatic spread where a standard work-up does not find the source organ. The legal question is whether that work-up was adequate and prompt under the Dunne standard. If a slow or incomplete investigation cost you a treatment opportunity or shortened your life, a cancer misdiagnosis claim may follow.
Contents
What cancer of unknown primary means
Cancer of unknown primary is a confirmed metastatic cancer for which a standard set of investigations does not reveal the organ where it started. Doctors can see the metastasis on a scan and confirm cancer on a biopsy, yet the original site of the secondary deposits stays hidden. The European Society for Medical Oncology defines CUP as a cancer for which a standardised work-up fails to identify the primary ESMO Clinical Practice Guideline (Updated 2023) [3]. The diagnosis is reached only after that search is done properly.
This page is for people told they have a metastatic cancer with no known source, and for families who suspect the investigation was slow or incomplete. It differs from a single misread scan or biopsy and from a general delayed diagnosis, because the issue is the adequacy of the whole search rather than one missed test.
Understanding the claim is the first step toward deciding whether to pursue compensation for the injury in Ireland.
CUP is uncommon and becoming rarer. The National Cancer Registry records just under 400 cases a year, around 2 to 3 percent of invasive cancers NCRI Cancer Trends 36 (2019) [1]. The median age is in the seventies, and it attributes the steady fall in incidence, over 5 percent a year, to better diagnosis. That matters legally: as investigation improves a genuine dead-end becomes rarer, so whether a work-up met the standard becomes a sharper question.
MUO, provisional CUP and confirmed CUP: where the delay happens
The terms you may hear, MUO and CUP, describe the same problem at different stages, and most avoidable delay happens at the early stage. Malignancy of undefined origin (MUO) is a metastatic cancer with no primary on the first set of tests. As the work-up continues it becomes provisional CUP, and only after a full standardised search with no primary found is it confirmed cancer of unknown primary.
This staging matters for a claim. The window where investigation can stall or be cut short is the MUO stage, before a patient is escalated to specialist review. Studies of these patients show over half first present as an emergency admission rather than through a planned pathway. That makes a prompt, owned work-up even more important British Journal of Cancer, regional CUP team analysis [15].
Why the primary is missing, and Ireland’s pathway gap
Sometimes the primary is genuinely undetectable, and sometimes it is missed because the search stopped too soon. A primary can be tiny, can have been shed by the body, or can sit in an organ that scans read poorly. In those cases no competent team would be criticised. The Irish Cancer Society explains the condition for patients and families and runs a confidential support line for anyone affected Irish Cancer Society [2].
Ireland has a structural gap that makes delay more likely. Rapid Access Clinics give fast, organised pathways for four cancers only, breast, lung, prostate and melanoma Citizens Information, Cancer services [4]. A patient with spread but no obvious source fits none of these clinics, so the work-up can pass between specialties without a single team owning it. There is no national clinical guideline in Ireland dedicated to CUP, unlike the United Kingdom, so responsibility for keeping the investigation moving is often unclear.
Plain point: The absence of a rapid-access route for CUP is not itself negligence. It is the backdrop. The legal question is whether the individual clinicians who did have the patient acted with ordinary care in moving the work-up forward.
How an Irish CUP claim differs from the UK
Irish CUP claims are decided under Irish law and the Irish system, which differ from the UK in ways that matter. The standard of care is the Dunne test, not the Bolam test used in England and Wales. UK guidance that requires a dedicated CUP team in every cancer centre does not apply here. Ireland has no equivalent national pathway, so the UK rules are not a guide to your rights.
Two further differences are practical. Ireland has no two-week or faster-diagnosis referral standard of the kind used in the NHS, so timeliness is judged against ordinary care under Dunne rather than a fixed target. Where a death occurs, Irish dependants share a single solatium capped at €35,000, which is a different scheme from UK bereavement damages.
Where negligence lies in a CUP pathway
Negligence in a CUP case rarely concerns the failure to find an invisible primary, but specific, provable failures in how the search was run. The standard comes from Dunne v National Maternity Hospital [1989] IR 91 [5], reaffirmed by the Supreme Court in Morrissey v HSE [2020] IESC 6 [6]. A clinician is negligent where they make a failure that no practitioner of equal status, acting with ordinary care, would have made. The test looks at the standard at the time, not with hindsight.
Defendants tend to argue inherent obscurity, that the hidden primary made delay inevitable. That argument is answered by pointing to the parts of the pathway within the team’s control. Common breach points, each needing expert evidence, include slow imaging, an incomplete pathology assessment that omits standard immunohistochemistry, and a failure to escalate clear metastatic disease to oncology review. A related issue is an abnormal result, such as an incidental finding on an earlier scan, that was generated but never acted on.
A minority of CUP cases belong to a favourable subset that behaves like a known cancer and responds to specific treatment. The ESMO guideline lists these subsets and notes that around 80 percent of patients fall into the unfavourable group [3]. Where a favourable subset is missed because the pathology or molecular work was not completed, the patient can be denied treatment that changes their course. Molecular and genomic profiling in Irish oncology forms part of this evolving standard of care HRB Open Research, Molecular Diagnostics in Irish Oncology [12].
An honest limit: not every delay is negligent. In Afolabi v Southdoc Services Ltd [2026] IEHC 110 the High Court confirmed that watchful waiting can be reasonable where the doctor documents clear safety-netting advice Afolabi v Southdoc [2026] IEHC 110 [7]. A claim depends on a failure that crosses the Dunne line, paired with proof of harm. This overlaps with, but differs from, a clear failure to refer for investigation.
Favourable subsets: when a missed CUP was treatable
A minority of CUP cases match a recognised pattern that is treated like a known cancer, and missing that pattern can be the difference that founds a claim. The ESMO guideline sets out these favourable subsets and the treatment each implies ESMO Clinical Practice Guideline (Updated 2023) [3]. If your case fits one of them, it is worth asking whether the pattern was recognised and acted on.
| Pattern | Usually treated as |
|---|---|
| A single site or limited spread | Local treatment, surgery or radiotherapy, as if early-stage disease |
| Isolated armpit nodes in a woman | Breast cancer, with breast MRI required before the diagnosis is settled |
| Spread across the abdomen in a woman | Ovarian cancer protocols |
| Squamous nodes in the neck | Head and neck cancer |
| Bone spread with a raised PSA in a man | Prostate cancer |
| A bowel-type pattern on testing | Colorectal cancer protocols |
What an adequate metastatic work-up involves
An adequate work-up follows a recognised sequence, and a claim usually points to a specific stage that was skipped or delayed. The table sets out the standard stages described in the ESMO guideline and where each can go wrong. It is a guide to the pathway, not a substitute for an expert report on your records.
| Stage | What competent care looks like | How it can go wrong |
|---|---|---|
| Imaging | Prompt CT with contrast of the relevant regions, with further imaging if the primary is not seen | Avoidable delay in arranging scans, or stopping after one inconclusive scan |
| Pathology | Biopsy with a structured immunohistochemistry panel to point toward the tissue of origin | Incomplete panel, or a poorly differentiated deposit labelled as a primary of one organ in error |
| Risk and subtype | Performance status and blood markers recorded, and treatable favourable subsets actively considered | A favourable subset missed, so treatment that could have helped is never offered |
| Escalation | Timely referral to oncology and a multidisciplinary team that owns the case | The patient drifts between teams with no one driving the investigation |
Proving causation and loss of chance
A claim must show that the failure, on the balance of probabilities, caused harm, and Irish law accepts the loss of a chance as a real harm. CUP carries a poor outlook. The National Cancer Registry records a median survival under three months and a five-year net survival of about 13 percent [1]. Defendants use those figures to argue that the cancer, not the delay, dictated the outcome.
That argument does not end a case. Irish courts can compensate the loss of a better outcome or a shortened life even where the prognosis was poor. This principle is associated with Philp v Ryan [2004] IESC 105 [8]. The doctrine remains unsettled at the margins, so the evidence must be built carefully.
The point we look for is concrete. Did the delay or the incomplete work-up remove a real treatment opportunity, push the disease to a worse stage, or take away months of better-quality life. How a staging change becomes legal harm is set out in our explanation of loss of chance, which feeds directly into any claim for reduced life expectancy.
What a CUP claim can include
Compensation in a clinical negligence claim has two parts, general damages for the harm itself and special damages for financial loss. General damages cover pain, suffering and loss of quality of life, and are assessed by reference to the Judicial Council’s Personal Injuries Guidelines 2021 Personal Injuries Guidelines 2021 [10]. Awards are not fixed and vary with the facts of each case.
In serious cancer claims the larger figure is usually special damages, which are not capped. These can include the cost of care, loss of earnings now and in the future, medical and travel expenses, and the costs that follow a shortened life.
A clinical negligence claim differs from an ordinary personal injury claim in one procedural respect. Most such claims bypass the Injuries Resolution Board (IRB) and proceed directly through the High Court, where a dedicated Clinical Negligence List now manages these cases.
Where a serious incident has occurred, the family may also be entitled to open disclosure. The Patient Safety Act 2023, in force since 26 September 2024, can require a meeting and a written account of what happened Patient Safety Act 2023 [11]. Our page on compensation amounts explains the heads of loss in more detail.
Considering a claim for a relative or for yourself? We offer a no obligation, confidential call to talk through what happened and whether the work-up met the standard. Phone 01 9036408 or use the enquiry form. There is no pressure and no cost to ask.
If a relative has died: fatal claims
Because most cancer of unknown primary diagnoses prove fatal, many CUP claims are brought by bereaved families rather than patients. Irish law creates two claims after a wrongful death. The estate can recover the person’s own losses before death, and the dependants can recover their future financial loss, which is not capped Civil Liability Act 1961 [13]. In most cases that loss of dependency is the larger part of the claim.
A separate fixed sum for mental distress, the solatium, is capped at €35,000 in total and shared among all dependants, whatever their number S.I. No. 6 of 2014 [14]. One claim is brought for the whole family, so it helps to identify every dependant early. The deadline is two years from the death or from the dependants’ date of knowledge.
Time limits and date of knowledge
The general time limit for a clinical negligence claim in Ireland is two years less one day. It runs from your date of knowledge, which can be later than the diagnosis. The clock starts when you knew, or ought reasonably to have known, that a significant injury was connected to the care you received. The two-year period was set by section 7 of the Civil Liability and Courts Act 2004, which amended the Statute of Limitations (Amendment) Act 1991 [9]; the 1991 Act governs how the date of knowledge is worked out.
Date of knowledge can be unusually contested in CUP cases. The injury that founds the claim is the avoidable delay or the incomplete work-up, not the fact that the primary was never found. Many families only learn that a fuller investigation might have changed things when an independent expert reviews the records, which can be well after the original diagnosis.
Because this is fact-sensitive, the safest course is to get advice early rather than assume the deadline has passed. Our guidance on the date of knowledge sets out how the rule is applied. Where a death has occurred, dependants have separate timelines, and a child’s own two years runs from their eighteenth birthday.
How we investigate a cancer of unknown primary claim
We test one question above all, whether the metastatic work-up met the Dunne standard. In practice that means gathering the full record of every investigation and its timing, because the chronology is usually where a CUP case is won or lost. We then instruct independent experts, typically an oncologist and a pathologist. They can say whether the search was adequate and prompt, and whether any failure changed the outcome.
The records decide these cases, so we gather them in full. The most important are:
- The imaging record with dates, showing every scan and how long each took to arrange.
- The biopsy and pathology reports, including the immunohistochemistry panel that was used.
- Any multidisciplinary team notes, showing which team took ownership of the case.
- GP and referral letters with dates, showing when concerns were raised and acted on.
- Any record of risk assessment and the treatment options that were discussed.
- For a bereaved family, the death certificate and any post-mortem or coroner’s findings.
From there the path is straightforward. We give a no obligation, confidential view on whether the work-up met the standard, gather the records, and put the evidence to independent experts. If their opinion supports a claim, we issue a letter of claim and, where needed, proceedings in the High Court’s Clinical Negligence List.
We act for patients living with CUP and for bereaved families across Ireland. As personal injury solicitors in Dublin, we know how heavy it is to be told that cancer has spread with no source found. We keep the process clear and humane. If you want a careful, honest assessment of whether there is a claim, we are glad to talk it through.
Talk to a solicitor. Call Gary Matthews Solicitors on 01 9036408 for a no obligation, confidential discussion, or send an enquiry and we will call you back.
The questions below move from the core test into the practical edge cases that come up most often when families first look at a cancer of unknown primary claim.
Common questions
Can I claim if the primary was never found?
Yes, potentially. A claim does not depend on identifying the primary. It depends on whether the metastatic work-up was adequate and prompt under the Dunne standard. What matters is whether any failure caused harm, such as a worse stage or lost treatment.
Is a cancer of unknown primary diagnosis always negligence?
No. Some primaries are genuinely undetectable even with the best care, and watchful waiting with documented safety-netting can be reasonable. Negligence requires a failure that no competent practitioner would have made, supported by expert evidence and proof of harm.
How do I prove the delay or inadequate work-up caused harm?
Through expert evidence. An oncologist and a pathologist review the timeline and the investigations. They give an opinion on whether earlier or fuller work-up would have changed staging, treatment or life expectancy on the balance of probabilities.
What does an adequate metastatic work-up include in Ireland?
Prompt cross-sectional imaging, a biopsy with a structured immunohistochemistry panel, recorded risk assessment, active consideration of treatable favourable subsets, and timely escalation to oncology and a multidisciplinary team. A claim usually points to one stage that was skipped or delayed.
Is there a rapid access clinic for unknown primary cancer in Ireland?
No. Rapid Access Clinics cover breast, lung, prostate and melanoma only. A patient with metastatic disease and no obvious primary has no dedicated fast pathway, which is part of why delay can occur.
What is the time limit for a CUP claim in Ireland?
Generally two years less one day, running from your date of knowledge rather than the date of diagnosis. Because that date is often established only after an expert reviews the records, you should seek advice early rather than assume the deadline has passed.
Can a poor prognosis still support a claim?
Yes. Irish law can compensate the loss of a chance of a better outcome or a shortened life even where the prognosis was already poor. A missed favourable subset, which can respond to specific treatment, is one situation where the delay may be decisive.
Do I need a UK expert for a CUP claim?
Not necessarily. What matters is an independent oncologist and pathologist who can speak to the standard of care and to causation. We instruct experts based on the issues in your case, wherever the right expertise sits.
What if my relative died from cancer of unknown primary?
Dependants can bring a fatal claim under the Civil Liability Act 1961. It covers the uncapped loss of financial dependency, a shared mental-distress payment capped at €35,000, and funeral costs. The deadline is two years from the death or your date of knowledge.
Could my cancer have been a favourable subset that was treatable?
Possibly. A minority of CUP cases match a pattern, such as isolated armpit nodes or squamous neck nodes, that is treated like a known cancer. If yours fits one, the question is whether that pattern was recognised and acted on.
Can I make a cancer of unknown primary claim in Ireland?
Yes, where the evidence supports it. The question is not the missing primary but whether the metastatic work-up met the Dunne standard, and whether a delay or gap caused harm. A solicitor and independent experts assess your records to answer that.
What is the difference between MUO and CUP?
They describe the same illness at different stages. Malignancy of undefined origin (MUO) is the early label before the source is searched for. Cancer of unknown primary is the confirmed diagnosis after a full work-up finds no primary. Most avoidable delay happens at the MUO stage.
Is cancer of unknown primary negligence judged the same in Ireland as the UK?
No. Ireland uses the Dunne test, not the UK Bolam test, and UK structures such as dedicated CUP teams and faster-diagnosis targets do not apply. Your rights are governed by Irish law.
References
- National Cancer Registry Ireland. Cancer Trends 36, Cancer of Unknown Primary (2019). Incidence, median age, mortality and survival.
- Irish Cancer Society. Cancer of unknown primary (CUP) (Updated October 2025). Patient information and support.
- Krämer A, Bochtler T, Pauli C, et al. Cancer of unknown primary, ESMO Clinical Practice Guideline, Annals of Oncology (2023). Standardised work-up and favourable and unfavourable subsets.
- Citizens Information. Cancer services. Rapid Access Clinics for breast, lung, prostate and melanoma.
- Dunne v National Maternity Hospital [1989] IR 91. Standard of care in clinical negligence.
- Morrissey v HSE [2020] IESC 6. Supreme Court reaffirmation of the Dunne principles.
- Afolabi v Southdoc Services Ltd [2026] IEHC 110. Watchful waiting and documented safety-netting.
- Philp v Ryan [2004] IESC 105. Loss of chance and reduced life expectancy.
- Civil Liability and Courts Act 2004, s.7, amending the Statute of Limitations (Amendment) Act 1991. Two-year limitation period and date of knowledge.
- Personal Injuries Guidelines 2021, Judicial Council of Ireland. General damages.
- Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023. Open disclosure duty.
- Walsh N, et al. Overview of Molecular Diagnostics in Irish Clinical Oncology, HRB Open Research. Molecular profiling context in Ireland.
- Civil Liability Act 1961. Fatal injury claims, estate and dependency.
- S.I. No. 6 of 2014. Solatium for mental distress capped at €35,000.
- Stares M, et al. Characterisation and outcomes of patients referred to a regional cancer of unknown primary team, British Journal of Cancer (2021). MUO, provisional and confirmed CUP spectrum and emergency presentation.
This information is for educational purposes only and does not constitute legal advice. Every case is different and outcomes vary. Time limits depend on the facts and can be shorter than you expect. Consult a qualified solicitor for advice specific to your situation. Gary Matthews Solicitors is regulated by the Law Society of Ireland. In contentious business a solicitor may not calculate fees or other charges as a percentage or proportion of any award or settlement.
Gary Matthews Solicitors
Medical negligence solicitors, Dublin
We help people every day of the week (weekends and bank holidays included) that have either been injured or harmed as a result of an accident or have suffered from negligence or malpractice.
Contact us at our Dublin office to get started with your claim today
